Umbilical vein oxytocin in the management of retained placenta: an alternative to manual removal of placenta?

Pei Shan Lim, Surinder Singh, Alice Lee, Muhammad Abdul Jamil Muhammad Yassin

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Retained placenta is potentially life threatening due to possible complications associated with manual removal. Our aim was to determine whether umbilical vein injection of oxytocin in saline reduces the need for manual removal of placenta. This was a randomised controlled trial conducted at a tertiary hospital from December 2002 to March 2004. A total of 61 women delivering singletons, who had no sign of placental separation 20 min after vaginal delivery, were randomised to receive either intra-umbilical oxytocin 100 IU diluted in 30 ml of saline or controlled cord traction only. Manual removal was done if the placenta was not expelled in another 30 min in both arms. There was a significant reduction in the rate of subsequent manual removal of placenta (30 vs. 67.7%, p < 0.05), incidence of uterine atony (3.3 vs. 25.8%, p < 0.05) and the need for uterotonic agents (33.3 vs. 64.5%, p < 0.05) in the oxytocin group when compared with the control group. No significant differences were found in the need for blood transfusion, uterine curettage, incidence of postpartum haemorrhage and haemoglobin level reduction. Intra-umbilical vein oxytocin injection is clinically effective for the management of a retained placenta.

Original languageEnglish
Pages (from-to)1073-1079
Number of pages7
JournalArchives of Gynecology and Obstetrics
Volume284
Issue number5
Publication statusPublished - Nov 2011

Fingerprint

Retained Placenta
Umbilical Veins
Oxytocin
Placenta
Uterine Inertia
Umbilicus
Postpartum Hemorrhage
Injections
Curettage
Incidence
Traction
Tertiary Care Centers
Blood Transfusion
Hemoglobins
Randomized Controlled Trials
Control Groups

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Umbilical vein oxytocin in the management of retained placenta : an alternative to manual removal of placenta? / Lim, Pei Shan; Singh, Surinder; Lee, Alice; Muhammad Yassin, Muhammad Abdul Jamil.

In: Archives of Gynecology and Obstetrics, Vol. 284, No. 5, 11.2011, p. 1073-1079.

Research output: Contribution to journalArticle

Lim, Pei Shan ; Singh, Surinder ; Lee, Alice ; Muhammad Yassin, Muhammad Abdul Jamil. / Umbilical vein oxytocin in the management of retained placenta : an alternative to manual removal of placenta?. In: Archives of Gynecology and Obstetrics. 2011 ; Vol. 284, No. 5. pp. 1073-1079.
@article{d3b329f68e18423d83265e53e60e86f4,
title = "Umbilical vein oxytocin in the management of retained placenta: an alternative to manual removal of placenta?",
abstract = "Retained placenta is potentially life threatening due to possible complications associated with manual removal. Our aim was to determine whether umbilical vein injection of oxytocin in saline reduces the need for manual removal of placenta. This was a randomised controlled trial conducted at a tertiary hospital from December 2002 to March 2004. A total of 61 women delivering singletons, who had no sign of placental separation 20 min after vaginal delivery, were randomised to receive either intra-umbilical oxytocin 100 IU diluted in 30 ml of saline or controlled cord traction only. Manual removal was done if the placenta was not expelled in another 30 min in both arms. There was a significant reduction in the rate of subsequent manual removal of placenta (30 vs. 67.7{\%}, p < 0.05), incidence of uterine atony (3.3 vs. 25.8{\%}, p < 0.05) and the need for uterotonic agents (33.3 vs. 64.5{\%}, p < 0.05) in the oxytocin group when compared with the control group. No significant differences were found in the need for blood transfusion, uterine curettage, incidence of postpartum haemorrhage and haemoglobin level reduction. Intra-umbilical vein oxytocin injection is clinically effective for the management of a retained placenta.",
author = "Lim, {Pei Shan} and Surinder Singh and Alice Lee and {Muhammad Yassin}, {Muhammad Abdul Jamil}",
year = "2011",
month = "11",
language = "English",
volume = "284",
pages = "1073--1079",
journal = "Archives of Gynecology and Obstetrics",
issn = "0932-0067",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Umbilical vein oxytocin in the management of retained placenta

T2 - an alternative to manual removal of placenta?

AU - Lim, Pei Shan

AU - Singh, Surinder

AU - Lee, Alice

AU - Muhammad Yassin, Muhammad Abdul Jamil

PY - 2011/11

Y1 - 2011/11

N2 - Retained placenta is potentially life threatening due to possible complications associated with manual removal. Our aim was to determine whether umbilical vein injection of oxytocin in saline reduces the need for manual removal of placenta. This was a randomised controlled trial conducted at a tertiary hospital from December 2002 to March 2004. A total of 61 women delivering singletons, who had no sign of placental separation 20 min after vaginal delivery, were randomised to receive either intra-umbilical oxytocin 100 IU diluted in 30 ml of saline or controlled cord traction only. Manual removal was done if the placenta was not expelled in another 30 min in both arms. There was a significant reduction in the rate of subsequent manual removal of placenta (30 vs. 67.7%, p < 0.05), incidence of uterine atony (3.3 vs. 25.8%, p < 0.05) and the need for uterotonic agents (33.3 vs. 64.5%, p < 0.05) in the oxytocin group when compared with the control group. No significant differences were found in the need for blood transfusion, uterine curettage, incidence of postpartum haemorrhage and haemoglobin level reduction. Intra-umbilical vein oxytocin injection is clinically effective for the management of a retained placenta.

AB - Retained placenta is potentially life threatening due to possible complications associated with manual removal. Our aim was to determine whether umbilical vein injection of oxytocin in saline reduces the need for manual removal of placenta. This was a randomised controlled trial conducted at a tertiary hospital from December 2002 to March 2004. A total of 61 women delivering singletons, who had no sign of placental separation 20 min after vaginal delivery, were randomised to receive either intra-umbilical oxytocin 100 IU diluted in 30 ml of saline or controlled cord traction only. Manual removal was done if the placenta was not expelled in another 30 min in both arms. There was a significant reduction in the rate of subsequent manual removal of placenta (30 vs. 67.7%, p < 0.05), incidence of uterine atony (3.3 vs. 25.8%, p < 0.05) and the need for uterotonic agents (33.3 vs. 64.5%, p < 0.05) in the oxytocin group when compared with the control group. No significant differences were found in the need for blood transfusion, uterine curettage, incidence of postpartum haemorrhage and haemoglobin level reduction. Intra-umbilical vein oxytocin injection is clinically effective for the management of a retained placenta.

UR - http://www.scopus.com/inward/record.url?scp=84875283530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875283530&partnerID=8YFLogxK

M3 - Article

C2 - 21136267

AN - SCOPUS:84875283530

VL - 284

SP - 1073

EP - 1079

JO - Archives of Gynecology and Obstetrics

JF - Archives of Gynecology and Obstetrics

SN - 0932-0067

IS - 5

ER -